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Abstract
Objectives To describe the views of the British public on the
use of personal medical data by the National Cancer Registry
without individual consent, and to assess the relative
importance attached by the public to personal privacy in
relation to public health uses of identifiable health data.
Design Cross sectional, face to face interview survey.
Setting England, Wales, and Scotland.
Participants 2872 respondents, 97% of those who took part in
the Office for National Statistics’ omnibus survey, a national
multistage probability sample, in March and April 2005
(response rates 62% and 69%, respectively).
Results 72% (95% confidence interval 70% to 74%) of all
respondents did not consider any of the following to be an
invasion of their privacy by the National Cancer Registry:
inclusion of postcode, inclusion of name and address, and the
receipt of a letter inviting them to a research study on the basis
of inclusion in the registry. Only 2% (2% to 3%) of the sample
considered all of these to amount to an invasion of privacy.
Logistic regression analysis showed that the proportions not
concerned about invasion of privacy varied significantly by
country, ethnicity, socioeconomic status, and housing tenure,
although in all subgroups examined most respondents had no
concerns. 81% (79% to 83%) of all respondents said that they
would support a law making cancer registration statutory.
Conclusions Most of the British public considers the
confidential use of personal, identifiable patient information by
the National Cancer Registry for the purposes of public health
research and surveillance not to be an invasion of privacy.
Introduction
Epidemiological surveillance of the changing incidence,
prevalence, and outcome of disease is essential for the delivery of
effective health services and public health interventions. Since
the year 2000, however, public health research has been
disrupted because of a climate of concern about the ethics and
legality of using identifiable data from patients’ records.1–4 Prob-
lems have resulted from new requirements to obtain consent
from individual patients before information about them can be
used in ways that were previously considered unremarkable—for
instance, the inclusion of patient information in cancer registries,
the compilation of information from databases for research
projects, and the identification of appropriate patients by
researchers for invitation to studies. Public health research
requires information about the whole population, and biases
arising from incomplete data can make the results unreliable,
invalid, or misleading.
Current problems in the use of identifiable data for public
health research in the United Kingdom are often attributed to
the Data Protection Act 1998,5 but this is only partially accurate.
The 1998 act implements the European directive on data
protection,6 but its implementation has not caused problems in
all European countries.7 The act codifies the conditions under
which research can be done. It makes explicit provision for the
use of identifiable data without individuals’ consent for the “pur-
poses of preventive medicine, medical diagnosis, the provision of
care and treatment or the management of health-care services.”
This provision is subject to the data being processed by a health
professional or person with an equivalent duty of confidentiality,
and provided the information is not used to make decisions
about the individual, will not cause substantial damage or
distress, nor be published in a way that allows identification. Vari-
able interpretations of the act (box 1)8–10 have, however, led to a
climate of uncertainty and difficulties in carrying out public
health research. The position has been complicated by guidance
from the General Medical Council11 and the NHS,12 and the
creation of the Patient Information Advisory Group under the
Health and Social Care Act 2001.13
The NHS code of practice on confidentiality states that it
cannot be assumed that patients are happy for identifiable infor-
mation about them to be used for purposes other than their
direct care (box 2),12 but there has been relatively little research
Box 1 Comments about the Data Protection Act 1998
The 1998 act allows medical data to be used for any medical
research purpose without the need for the consent of individuals.
It is not necessary to define the term “medical research,” nor to
make specific provision for it to include the monitoring of public
health, which for these purposes is regarded as medical research
Lord Falconer QC, Minister of State at the Cabinet Office, 20008
It is clear that many practitioners are confused between the
requirements of the Data Protection Act and those of the various
regulatory and representative bodies within the sector . . . It is a
common misconception, for instance, that the act always requires
consent of data subjects to the processing of their data
Elizabeth France, Information Commissioner, 20029
The two most widely held misconceptions are that the act
creates an overarching requirement to obtain explicit consent for
the processing of all health data and that the requirements of the
act are additional to good professional standards, medical ethics
and confidentiality. In fact, in most cases the act will almost never
require consent for the processing of data for research purposes,
unless consent is also a more general legal requirement
Phil Boyd, Information Commissioner’s Office, 200310
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on patients’ views. So far, no study has asked respondents to
make a judgment about the balance between personal privacy
and public health research.
We sought the views of the British public on the acceptability
of identifiable information being used for public health purposes
in the context of a real example. The National Cancer Registry
collates data from nine regional cancer registries in England,
with separate national registries in Scotland, Wales, and
Northern Ireland. Data flows to the National Cancer Registry
were disrupted after publication of new guidance from the Gen-
eral Medical Council in 2000,11 later revised. Data collection con-
tinues under section 60 of the Health and Social Care Act 2001
but this support is temporary.14 15 A bill to make the registration
of cancer a statutory requirement in England, Wales, and North-
ern Ireland is currently before parliament.16
Methods
We designed nine questions on cancer registration and personal
privacy for inclusion in the omnibus survey run by the Office for
National Statistics.We were inspired by a Canadian survey on the
same topic (E Holowaty, personal communication, July 2002).
Question 5 is based on the wording of the UK Department of
Health website.17 We tested the questions using 29 cognitive
interviews (data not shown). The final questions ensured that
interviewees understood the purpose of the National Cancer
Registry and that data transfers at the moment were without
patients’ consent. The omnibus survey team commented on the
questions during development and approved their final form.
The questions were included in the March and April 2005
rounds of the omnibus survey, a national multistage probability
cluster design survey. Of the 3000 addresses selected in March
and the 2010 selected in April, 2762 and 1819, respectively, were
eligible as they contained a private household. When addresses
contained more than one household the National Office for Sta-
tistics used a standard procedure to select one at random. In
households with more than one adult, one person aged 16 or
more was selected at random. If the person selected was unavail-
able or declined to be interviewed this was recorded as a
non-response. Face to face interviews were carried out with 1703
people in March 2005 and 1252 people in April (response rates
62% and 69%). We combined the data for analysis.
Analyses were carried out using Stata 9.0, taking account of
the unequal probability of selection in households caused by
varying household size and the increased standard errors associ-
ated with the clustering of interviews within postcode sectors.
Proportions and 95% confidence intervals are used to describe
the estimates of opinion (weighted data shown, unweighted
denominators given in tables) and to examine which factors are
associated with support for cancer registration and with being
unconcerned about invasion of privacy, the latter being a group-
ing of those who answered “no” to questions 7, 8, and 9. We
entered into logistic regression models those factors with P val-
ues less than 0.05 in the unifactorial analyses. Results are
presented as adjusted proportions.
Results
Of the 2955 interviewees, 2872 (97%) answered all nine
questions (table 1). Thirty people (1%) refused to answer the
questions and a further 53 (2%), a minority who completed
telephone interviews, were asked none or only some of the ques-
tions. Table 2 shows the characteristics of respondents. Compari-
son with census data (not shown) showed that respondents were
closely representative of the population, albeit with a small
excess of owner occupiers.18
Most people (n = 2363, 82%) had not heard of the National
Cancer Registry but the vast majority (n = 2737, 95%) thought
that the information it collected was useful (questions 4 and 5,
table 1). Over four fifths of responders (n = 2335, 81%) said that
they would support legislation to underpin the National Cancer
Registry (question 6). Small but significant differences in levels of
support were found according to age, ethnicity, socioeconomic
status, housing tenure, and the experience of cancer in the
immediate family. Only socioeconomic status and housing
tenure remained significant after adjustment, with those living in
rented accommodation and those of “not classified” socioeco-
nomic status showing slightly lower levels of support (table 2).
Most respondents (n = 2740, 95%) did not believe that a let-
ter from their primary care trust inviting them to a cancer
screening test was an invasion of privacy (question 3). Similarly,
over 80% of respondents did not consider that the confidential
inclusion of their postcode or name and address in the registry,
or the receipt of a letter inviting them to take part in a research
study, was an invasion of their privacy (questions 7 to 9). The sce-
nario that caused most disquiet was the inclusion of name and
address (question 8), with 16% of respondents (n = 446) consid-
ering this an invasion of privacy. In all, 2068 respondents (72%,
95% confidence interval 70% to 74%) indicated that none of
these scenarios (inclusion of postcode in the registry, inclusion of
name and address, and receipt of an invitation to a research
study) was an invasion of privacy. Only 61 respondents (2%, 2%
to 3%) saw all three scenarios as an invasion of their privacy. The
opinions of the other 714 respondents varied. Taking the
opinion that none of the scenarios was an invasion of privacy as
a marker of a lack of concern about invasion of privacy, small but
significant differences were found according to country,
ethnicity, socioeconomic status, housing tenure, and the
experience of cancer in the immediate family. Each of these vari-
Box 2 Extracts from the NHS code of practice on
confidentiality
Many current uses of confidential patient information do not
contribute to or support the health care that a patient receives.
Very often these other uses are extremely important and provide
benefits to society—for example, medical research, protecting the
health of the public, health service management, and financial
audit. However, they are not directly associated with the health
care that patients receive and we cannot assume that patients
who seek health care are content for their information to be used
in these ways.
Key identifiable information includes:
• Patient’s name, address, full postcode, date of birth
• Pictures, photographs, videos, audiotapes, or other images of
patients
• NHS number and local identifiable codes for patients
• Anything else that may be used to identify a patient directly or
indirectly
For example, rare diseases, drug treatments, or statistical analyses
which have very small numbers within a small population may
allow individuals to be identified.
Anonymised information
This is information which does not identify an individual directly,
and which cannot reasonably be used to determine identity.
Anonymisation requires the removal of name, address, full
postcode, and any other detail or combination of details that
might support identification.12
Research
page 2 of 5 BMJ Online First bmj.com
ables, except the experience of cancer in the family, remained
significant after adjustment, with the Scottish, those whose
ethnicity was not “white British,” those of lower socioeconomic
status, and those living in rented accommodation being more
likely to be concerned about invasion of privacy (table 2).
Discussion
The majority of the British public does not consider the
confidential use of personal, identifiable information by the
National Cancer Registry for the purposes of public health
research and surveillance to be an invasion of privacy.
Furthermore, four fifths of the public would support a law mak-
ing cancer registration statutory.
An advantage of this study is that we were able to pose ques-
tions about the uses of identifiable patient information within
the context of a real public health example, the National Cancer
Registry. This allowed respondents to consider both the private
good of privacy and the public good of public health
information when formulating their answers. The survey was
also a large scale national probability sample survey, carried out
on our behalf by the Office for National Statistics, an independ-
ent government agency with an excellent reputation for survey
quality and probity.
Table 1 Respondents’ views on cancer registration and privacy
Question
“Yes” “No” “Don’t know”
No of
respondents* % (95% CI)
No of
respondents* % (95% CI)
No of
respondents* % (95% CI)
1 To begin, could I please start by asking if you have,
or you have ever had, cancer?
174 6 (5 to 7) 2701 94 (93 to 95) — —
2 And have any members of your immediate family
(for instance, parents, children,
husband/wife/partner, brothers, sisters) ever had
cancer?
1298 45 (43 to 47) 1528
53 (51 to 56) 50 2 (1 to 2)
3 Many people get letters from their primary care
trust (previously called the health authority) about
screening tests for cancer, such as cervical smear
tests or bowel cancer screening. If your primary
care trust sent you a letter inviting you to a
screening test, do you think this would be an
invasion of your privacy?
93 3 (2 to 4) 2740
95 (94 to 97) 39 1 (1 to 2)
4 In the UK we have the National Cancer Registry,
which is a confidential NHS database of people who
have cancer. Have you ever heard of the National
Cancer Registry before?
479 17 (15 to 18) 2362
82 (81 to 84) 32 1 (1 to 2)
5 The National Cancer Registry is the only reliable
source of information for monitoring trends in the
risk of getting cancer and trends in cancer survival.
The information is used to compare the
effectiveness of cancer treatment around the
country, and to evaluate the success of cancer
screening programmes. Do you think this is useful
information for us to have in this country?
2737 95 (94 to 96) 68 2 (2 to 3)
69 2 (2 to 3)
6 In the USA, Denmark, Sweden, and many other
countries, all cases of cancer have to be notified to
the cancer registry by law. In future, there may
need to be a similar law in the UK, to ensure that
the National Cancer Registry continues to have the
information needed for monitoring cancer in the
UK. Would you support a new law that meant all
cases of cancer have to be notified to the National
Cancer Registry?
2335 81 (79 to 83) 343 12 (10 to 13)
194 7 (6 to 8)
7 Currently, cancer patients’ postcodes are
automatically included in the National Cancer
Registry. This can help the registry tell, for
example, if cancer is related to living around
polluted areas. If you had cancer and your
postcode was included in the National Cancer
Registry, to be held confidentially and under strict
security, do you think this would be an invasion of
your privacy?
243 8 (7 to 10) 2533 88 (87 to 90)
98 3 (3 to 4)
8 Currently, survival rates from cancer can only be
compared between regions of the country by
knowing cancer patients’ names and addresses. If
you had cancer and your name and address was
included automatically in the National Cancer
Registry, to be held confidentially and under strict
security, do you think this would be an invasion of
your privacy?
446 16 (14 to 17) 2326 81 (79 to 83)
101 4 (3 to 4)
9 Finally, suppose that a research group from a
university medical school wanted to do research
with people who had a particular type of cancer. If
you had cancer and the National Cancer Registry
sent you a letter, via your doctor, asking if you
wanted to take part in the research, do you think
this would be an invasion of your privacy?
261 9 (8 to 10) 2508 87 (86 to 89)
104 4 (3 to 5)
Questions are in order asked in survey.
*Denominators were 2873 weighted and 2869 unweighted, except for questions 1, 2, 3, and 6, which had small amounts of missing data.
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One limitation of the study was that within the constraint of
nine survey questions we were only able to concentrate on one
context, the public health use of identifiable information relating
to cancer. Cancer may be a topic that the public considers of par-
ticular importance or that evokes special sympathy in Britain.
Information from other studies, however, suggests that the find-
ings of this study may be more broadly generalisable. Two stud-
ies that examined rates of consent to health registers (the
Canadian stroke network register19 and the paediatric intensive
care audit network register in the United Kingdom20) found that
obstacles to consent were primarily due to logistical problems in
gaining access to patients to ask for consent; when it was possible
to ask patients or their representatives for permission to use
identifiable information, consent was almost always given.
Research across the European Union has also shown that
doctors and medical services are highly trusted with regard to
their use of individuals’ personal information, much more so
than tax authorities, banks, employers, and insurance and credit
card companies.21 This suggests that the confidential use of iden-
tifiable health information for research without individuals’ con-
sent has not so far damaged the public’s trust.
We are aware of only one previous study in which the public
was asked about their support for cancer registration.22 The study
was commissioned by the former West German government at
the time of proposed legislation in 1983. The findings were
broadly similar to ours: 87% of the public thought it important to
set up cancer registers, 78% reported that they would agree with
their data being reported and analysed if they developed cancer,
and 78% of the public, once fully informed, supported a new law
for cancer registration.
A recent discussion paper by the British Medical Association
advocated wider debate about the uses of identifiable health
information, asking to whom such information belongs and who
should benefit from its use—the authors, the data subjects, the
wider community, or the state?23 In the past few years, the
assumption has gained ground that the public would wish
primacy to be given to individual privacy over the public
interest,3 14 despite the lack of evidence on public opinion. The
NHS code of practice on confidentiality asserts that it cannot be
assumed that patients are happy for information about them to
be used for purposes other than direct patient care.12 Our
findings suggest the opposite—that is, one cannot assume that
Table 2 Factors associated with support for law on cancer registration and not being concerned about invasion of privacy
Variable No (%) insample
Support for law on cancer registration Not concerned about invasion of privacy
% (95% CI)
support law P value
Adjusted % (95%
CI)*† P value
% (95% CI) not
concerned P value
Adjusted % (95%
CI)*‡ P value
Sex:
Male 1319 (46) 80 (77 to 83)
0.284
—
—
73 (70 to 76)
0.462
—
—
Female 1557 (54) 82 (80 to 84) — 71 (68 to 74) —
Age group:
16-44 1315 (46) 79 (76 to 82)
0.040
80 (76 to 84)
0.681
70 (67 to 73)
0.154
—
—45-64 997 (35) 84 (81 to 86) 82 (77 to 86) 73 (70 to 77) —
≥65 564 (20) 82 (78 to 86) 81 (75 to 85) 74 (70 to 77) —
Country:
England 2506 (87) 81 (79 to 83)
0.136
—
—
72 (70 to 75)
0.005
75 (71 to 78)
0.004Wales 130 (5) 88 (80 to 94) — 79 (71 to 86) 81 (72 to 87)
Scotland 240 (8) 77 (68 to 84) — 62 (55 to 69) 65 (56 to 72)
Ethnicity:
White British 2532 (88) 82 (80 to 84)
0.049
80 (76 to 84)
0.293
73 (71 to 75)
<0.001
75 (71 to 78)
0.002
All other groups 335 (12) 76 (69 to 82) 76 (69 to 83) 63 (58 to 68) 66 (61 to 72)
Education:
Degree or higher 542 (19) 79 (74 to 82)
0.270 —
71 (67 to 75)
0.086Below degree 1496 (52) 82 (79 to 85) 74 (71 to 77)
No qualifications 837 (29) 82 (78 to 85) 69 (65 to 73)
Socioeconomic
status:
Managerial 988 (34) 81 (77 to 83)
0.002
80 (76 to 84)
0.023
74 (71 to 76)
<0.001
75 (71 to 78)
0.001
Intermediate 588 (20) 85 (82 to 88) 85 (81 to 89) 79 (75 to 82) 80 (75 to 84)
Manual 1060 (37) 82 (79 to 85) 83 (78 to 86) 69 (66 to 72) 71 (67 to 75)
Not classified 240 (8) 72 (63 to 79) 76 (67 to 83) 61 (54 to 68) 66 (58 to 73)
Housing tenure:
Owner occupier 2189 (76) 83 (81 to 85)
0.001
80 (76 to 84)
0.007
74 (71 to 76)
<0.001
75 (71 to 78)
0.019
Rents from local
authority or
housing
association
410 (14) 77 (72 to 82) 74 (66 to 80) 64 (60 to 69) 68 (61 to 74)
Rents privately 275 (10) 74 (67 to 79) 73 (64 to 79) 67 (61 to 73) 71 (64 to 77)
Ever had cancer?:
No 2701 (94) 81 (79 to 83)
0.168
—
—
72 (70 to 74)
0.912
—
—
Yes 174 (6) 85 (79 to 90) — 72 (64 to 78) —
Member of immediate
family ever had
cancer?:
No or don’t know 1578 (55) 80 (77 to 82)
0.023
80 (76 to 84)
0.154
70 (67 to 73)
0.034
75 (71 to 78)
0.100
Yes 1298 (45) 83 (81 to 85) 82 (78 to 86) 74 (71 to 77) 77 (74 to 81)
*Adjusted for other variables in model; values adjusted to reference category.
†Denominators were 2870 unweighted and 2873 weighted.
‡Denominators were 2862 unweighted and 2865 weighted.
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patients would be happy if their information was only used for
direct patient care and not also for other purposes such as pub-
lic health research and surveillance. It has been argued that
although individual consent is suitable in a clinical context, it is
neither adequate nor appropriate in relation to public policy,
including decisions about the public health uses of identifiable
data.24 Our findings provide a direct insight into public views and
suggest strong support for the confidential use of identifiable
data on cancer for public health purposes and for statutory can-
cer registration. Research on attitudes towards the public health
uses of identifiable data on other diseases, and the stimulation of
public debate, would both be desirable.
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What is already known on this topic
Most policies on the use of personal medical data assume
that the public will prioritise individual privacy over public
health uses of such data
Little evidence supports this assumption
Few studies have assessed public opinion on the uses of
identifiable medical data, without consent, for health
research and surveillance
What this study adds
The British public supports the use of identifiable cancer
data without consent for public health research
Relatively few people were concerned about invasion of
privacy in this context
The public strongly supports the National Cancer Registry
and that cancer registration should be required by law
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